UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Linc00941 fuels ribogenesis and protein synthesis by supporting robust cMYC translation in malignant pleural mesothelioma

Cancer letters, 2024-06, Vol.592, p.216950, Article 216950

2024

Volltextzugriff (PDF)

Molecular and Immunohistochemical Testing in Mesothelioma and Other Mesothelial Lesions

Archives of pathology & laboratory medicine (1976), 2024-05, Vol.148 (5), p.e77-e89

2024

Volltextzugriff (PDF)

Mesothelioma-Associated Fibroblasts Modulate the Response of Mesothelioma Patient-Derived Organoids to Chemotherapy via Interleukin-6

International journal of molecular sciences, 2024-05, Vol.25 (10), p.5355

2024

Volltextzugriff (PDF)

Defining and targeting tumor-associated macrophages in malignant mesothelioma

Proceedings of the National Academy of Sciences - PNAS, 2023-02, Vol.120 (9), p.e2210836120-e2210836120

2023

Volltextzugriff (PDF)

Mesothelioma-associated fibroblasts enhance proliferation and migration of pleural mesothelioma cells via c-Met/PI3K and WNT signaling but do not protect against cisplatin

Journal of experimental & clinical cancer research, 2023-01, Vol.42 (1), p.27-27, Article 27

2023

Volltextzugriff (PDF)

Can novel adipokines, asprosin and meteorin-like, be biomarkers for malignant mesothelioma?

Biotechnic & histochemistry, 2020-04, Vol.95 (3), p.171-175

2020

Volltextzugriff (PDF)

Expression and prognostic significance of KAP1 gene in malignant pleural mesothelioma

Zhonghua laodong weisheng zhiyebing zazhi, 2024-04, Vol.42 (4), p.258

2024

Volltextzugriff (PDF)

Intercellular interaction dictates cancer cell ferroptosis via NF2-YAP signalling

Nature (London), 2019-08, Vol.572 (7769), p.402-406

2019

Volltextzugriff (PDF)

Guidelines for Pathologic Diagnosis of Malignant Mesothelioma 2017 Update of the Consensus Statement From the International Mesothelioma Interest Group

Archives of pathology & laboratory medicine (1976), 2018-01, Vol.142 (1), p.89-108

2018

Volltextzugriff (PDF)

Analysis of expression of programmed cell death 1 ligand 1 (PD-L1) in malignant pleural mesothelioma (MPM)

PloS one, 2015-03, Vol.10 (3), p.e0121071-e0121071

2015

Volltextzugriff (PDF)

Iron addiction with ferroptosis-resistance in asbestos-induced mesothelial carcinogenesis: Toward the era of mesothelioma prevention

Free radical biology & medicine, 2019-03, Vol.133, p.206-215

Toyokuni, Shinya

2019

Volltextzugriff (PDF)

Tumor PD-L1 expression in malignant pleural and peritoneal mesothelioma by Dako PD-L1 22C3 pharmDx and Dako PD-L1 28-8 pharmDx assays

Human pathology, 2019-05, Vol.87, p.11-17

2019

Volltextzugriff (PDF)

Human CAR T cells with cell-intrinsic PD-1 checkpoint blockade resist tumor-mediated inhibition

The Journal of clinical investigation, 2016-08, Vol.126 (8), p.3130-3144

2016

Volltextzugriff (PDF)

Clinical and molecular validation of BAP1, MTAP, P53, and Merlin immunohistochemistry in diagnosis of pleural mesothelioma

Modern pathology, 2022-10, Vol.35 (10), p.1383-1397

2022

Volltextzugriff (PDF)

Novel insights into mesothelioma biology and implications for therapy

Nature reviews. Cancer, 2017-08, Vol.17 (8), p.475-488

2017

Volltextzugriff (PDF)

Restoring expression of miR-16: a novel approach to therapy for malignant pleural mesothelioma

Annals of oncology, 2013-12, Vol.24 (12), p.3128-3135

2013

Volltextzugriff (PDF)

The Immune Microenvironment, Genome-wide Copy Number Aberrations, and Survival in Mesothelioma

Journal of thoracic oncology, 2017-05, Vol.12 (5), p.850-859

2017

Volltextzugriff (PDF)

Statin suppresses Hippo pathway-inactivated malignant mesothelioma cells and blocks the YAP/CD44 growth stimulatory axis

Cancer letters, 2017-01, Vol.385, p.215-224

2017

Volltextzugriff (PDF)

Utility of Methylthioadenosine Phosphorylase Compared With BAP1 Immunohistochemistry, and CDKN2A and NF2 Fluorescence In Situ Hybridization in Separating Reactive Mesothelial Proliferations From Epithelioid Malignant Mesotheliomas

Archives of pathology & laboratory medicine (1976), 2018-12, Vol.142 (12), p.1549-1553

2018

Volltextzugriff (PDF)

Metabolic rewiring and redox alterations in malignant pleural mesothelioma

British journal of cancer, 2020-01, Vol.122 (1), p.52-61

2020

Volltextzugriff (PDF)

Intracavitary ‘T4 immunotherapy’ of malignant mesothelioma using pan-ErbB re-targeted CAR T-cells

Cancer letters, 2017-05, Vol.393, p.52-59

2017

Volltextzugriff (PDF)

Exosomal transfer of miR-126 promotes the anti-tumour response in malignant mesothelioma: Role of miR-126 in cancer-stroma communication

Cancer letters, 2019-10, Vol.463, p.27-36

2019

Volltextzugriff (PDF)

Ratio of intratumoral macrophage phenotypes is a prognostic factor in epithelioid malignant pleural mesothelioma

PloS one, 2014-09, Vol.9 (9), p.e106742-e106742

2014

Volltextzugriff (PDF)

Exosomal miR-16-5p as a target for malignant mesothelioma

Scientific reports, 2019-08, Vol.9 (1), p.11688-13, Article 11688

2019

Volltextzugriff (PDF)

1 – 25 von 1.575

Suche als RSS-Feed

Aktive Filter

ThemaMesothelioma

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.494)
Mit Volltextzugriff
(1.458)

Publikationsform

Artikel
(1.574)
Bücher
(1)

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Plos One
(117)
International Journal Of Molecular Sciences
(53)
Oncogene
(38)
Journal Of Thoracic Oncology
(33)
Bmc Cancer
(30)
Oncology Reports
(30)
Modern Pathology
(29)
Scientific Reports
(29)
British Journal Of Cancer
(28)
International Journal Of Oncology
(24)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Linc00941 fuels ribogenesis and protein synthesis by supporting robust cMYC translation in malignant pleural mesothelioma

Molecular and Immunohistochemical Testing in Mesothelioma and Other Mesothelial Lesions

Mesothelioma-Associated Fibroblasts Modulate the Response of Mesothelioma Patient-Derived Organoids to Chemotherapy via Interleukin-6

Defining and targeting tumor-associated macrophages in malignant mesothelioma

Mesothelioma-associated fibroblasts enhance proliferation and migration of pleural mesothelioma cells via c-Met/PI3K and WNT signaling but do not protect against cisplatin

Can novel adipokines, asprosin and meteorin-like, be biomarkers for malignant mesothelioma?

Expression and prognostic significance of KAP1 gene in malignant pleural mesothelioma

Intercellular interaction dictates cancer cell ferroptosis via NF2-YAP signalling

Comprehensive genomic analysis of malignant pleural mesothelioma identifies recurrent mutations, gene fusions and splicing alterations

Guidelines for Pathologic Diagnosis of Malignant Mesothelioma 2017 Update of the Consensus Statement From the International Mesothelioma Interest Group

Analysis of expression of programmed cell death 1 ligand 1 (PD-L1) in malignant pleural mesothelioma (MPM)

Iron addiction with ferroptosis-resistance in asbestos-induced mesothelial carcinogenesis: Toward the era of mesothelioma prevention

Tumor PD-L1 expression in malignant pleural and peritoneal mesothelioma by Dako PD-L1 22C3 pharmDx and Dako PD-L1 28-8 pharmDx assays

Human CAR T cells with cell-intrinsic PD-1 checkpoint blockade resist tumor-mediated inhibition

Clinical and molecular validation of BAP1, MTAP, P53, and Merlin immunohistochemistry in diagnosis of pleural mesothelioma

Novel insights into mesothelioma biology and implications for therapy

Restoring expression of miR-16: a novel approach to therapy for malignant pleural mesothelioma

The Immune Microenvironment, Genome-wide Copy Number Aberrations, and Survival in Mesothelioma

Statin suppresses Hippo pathway-inactivated malignant mesothelioma cells and blocks the YAP/CD44 growth stimulatory axis

Utility of Methylthioadenosine Phosphorylase Compared With BAP1 Immunohistochemistry, and CDKN2A and NF2 Fluorescence In Situ Hybridization in Separating Reactive Mesothelial Proliferations From Epithelioid Malignant Mesotheliomas

Metabolic rewiring and redox alterations in malignant pleural mesothelioma

Intracavitary ‘T4 immunotherapy’ of malignant mesothelioma using pan-ErbB re-targeted CAR T-cells

Exosomal transfer of miR-126 promotes the anti-tumour response in malignant mesothelioma: Role of miR-126 in cancer-stroma communication

Ratio of intratumoral macrophage phenotypes is a prognostic factor in epithelioid malignant pleural mesothelioma

Exosomal miR-16-5p as a target for malignant mesothelioma

Aktive Filter

Suchergebnisse filtern